微创品牌怎么样 申请店铺

微创医疗器械(上海)有限公司于一九九八年五月成立，为中国领先的医疗器械开发商、制造商及营销商，主要专注于治疗血管疾病及病变的微创介入产品。集团于2010年9月于香港联合交易所上市，股份编号：00853。

集团主要供应心血管器械和其他血管器械以及糖尿病器械，主要产品为第二代钴铬合金药物洗脱支架Firebird2。集团还供应其他血管支架，用于治疗身体其他部位的血管疾病及失调。集团亦销售极其细小的颅内支架、用于促进脑血管血液流量的灵活支架以及外科手术中使用的覆膜支架。

微创的产品于中国有逾1,100家医院使用，部分产品出口至中国境外的20多个国家，该等国家位于亚太地区(不包括中国)、南美及欧洲。

微创医疗器械(上海)有限公司大事记

1998年常兆华博士创立微创(上海)

2000年开始制造裸金属支架

2001年获四家上海市政府机构认定为高新技术企业，本集团在研发领域的成果获得认可

2003年商业性推出裸金属支架Mustang

2004年集团自行研发的药物洗脱支架产品Firebird正式推出

2006年集团设计及制造的胸腔段大动脉/大动脉覆膜支架产品获上海市政府授予科技进步二等奖

商业性推出HerculesT

2007年商业性推出Tango

2008年集团的Firebird2获上海市科学技术委员会授予上海市重点新产品证书

收购微创生命医学北京，发展胰岛素泵业务以治疗糖尿病

2009年于上海国际医学园区成立上海微创骨科医疗科技有限公司

于中国上海张江高科技园区收购一幅地块，现时正在该地块兴建一栋新的综合楼

2010年于上海国际医学园区成立上海微创电生理医疗科技有限公司

微创医疗于香港联合交易所有限公司主板上市

Established in May 1998, minimally invasive medical devices (Shanghai) Co., Ltd. is a leading developer, manufacturer and marketer of medical devices in China, focusing on minimally invasive interventional products for the treatment of vascular diseases and lesions. The group was listed on the stock exchange of Hong Kong in September 2010 with share number 00853. The group mainly supplies cardiovascular devices and other vascular devices as well as diabetes devices, and its main product is the second generation of cobalt chromium alloy drug-eluting stent Firebird 2. The group also supplies other vascular stents for the treatment of vascular diseases and disorders in other parts of the body. The group also sells extremely small intracranial stents, flexible stents for promoting cerebral blood flow, and covered stents used in surgery. Minimally invasive products are used in more than 1100 hospitals in China, and some of them are exported to more than 20 countries outside China, which are located in the Asia Pacific region (excluding China), South America and Europe. Event of minimally invasive medical devices (Shanghai) Co., Ltd. in 1998, Dr. Chang Zhaohua founded minimally invasive medical devices (Shanghai) to manufacture bare metal stents in 2000. In 2001, it was recognized as a high-tech enterprise by four Shanghai municipal government agencies. The achievements of the group in the field of research and development were recognized. In 2003, the group launched the bare metal stents, Mustang. In 2004, Firebird, a drug-eluting stent product developed by the group, was officially launched In 2006, the group designed and manufactured the thoracic artery / artery covered stent product, which was awarded the second prize of science and technology progress by Shanghai municipal government. In 2007, Hercules was commercially launched. In 2008, Tango group's Firebird 2 was awarded the Shanghai key new product certificate by Shanghai Municipal Science and Technology Committee. It acquired minimally invasive life medicine in Beijing and developed insulin pump business to treat diabetes in 2009 Shanghai minimally invasive orthopedic medical technology Co., Ltd. was established in Shanghai International Medical Park in 2010. It acquired a plot in Zhangjiang High Tech Park, Shanghai, China. Now it is constructing a new comprehensive building in the plot. In 2010, Shanghai International Medical Park established Shanghai minimally invasive electrophysiological Medical Technology Co., Ltd. minimally invasive Medical Technology Co., Ltd. listed on the main board of Hong Kong Stock Exchange Co., Ltd

本文链接： https://brand.waitui.com/90e97e605.html 联系电话：021-38954600